11/13/2013
https://congress.gov...
"There is some argument that is always made by the pharma companies that if there is some pushback on their pricing power, that somehow means they are not going to innovate. I find that to be bogus bec..."
"I would just urge us to try to look for some way where we address this patient choice issue, because I know a lot of my colleagues have that concern. I have that concern."
"the fact is that there is going to be a lot of resistance if there is an apprehension that a patient can't get the medication he or she needs."
"We have worked in a bipartisan manner on lowering drug costs over the last several years."